ASX:ANR

ANATARA LIFESCIENCES LTD

4W AVG VOLUME

64.39k

Data provided by Weblink | as of close 2020-01-28

4W AVG TURNOVER

$18.04k

ANATARA LIFESCIENCES LTD has not announced any current capital raises, but we are collecting interest for future raises.

Demand Registered for Next Raise

< $50k

Investors Interested in Next Raise

< 10

How Fresh Equities Works

1. Create Account

Complete your onboarding digitally in less than 3 minutes.

2. View Terms

View the full term sheet for the capital raise.

3. Bid for Allocation

Submit and track your bid online.

Capital Raise History

Company Overview

Anatara Lifesciences Ltd (ANR) is developing non-antibiotic oral solutions for gastrointestinal diseases in animals and humans. Company's initial focus is the development and commercialisation of Detach, which is a natural, plant-based, non-antibiotic therapy that prevents and treats diarrhoea in pigs.

Type

Listed Company

GICS Sub-industry

Biotechnology

Head Office

433 Logan Rd, Greenslopes QLD 4120, Australia

Website

www.anataralifesciences.com

Biotechnology

Health Care

Biotech & Health

Price Chart

Quarterly Cash Flows

The numbers below are derived from quarterly cash flow reports provided by the company. Fresh Equities does not guarantee that the information provided is accurate, you can read the associated report by clicking read more for the quarter. Always do your own research and do not rely on the information provided here as your only source of research.